Microbiome Diversity
Guidelines for e-signature use in global trials
Guidelines for e-signature use in global trials, including qualified e-signature and standard e-signature options.
By emily johnson · Sep 8, 2026
Tag: pharmaceuticals
Recovery Modalities
Sensorion gets green light for HearConnex trial
Sensorion's HearConnex trial gets green light for hearing loss treatment with gene therapy SENS-601.
By Samoyed · Sep 4, 2026
Nutrient Synergy
Alumis lupus drug advances after trial setback
Alumis advances its lupus drug to Phase III trials despite mixed Phase IIb results, targeting a specific patient subgroup for better outcomes.
By Samoyed · Sep 3, 2026
Somatic Drills
ESC 2026 AstraZeneca oral relaxin passes Phase II
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
By Samoyed · Sep 2, 2026
Endocrine Balance
Novartis Announces Positive Phase III Results for Remibrutinib
Novartis announces positive Phase III results for Remibrutinib, a new oral treatment for relapsing multiple sclerosis showing significant efficacy over teriflun
By Samoyed · Sep 1, 2026
Recovery Modalities
HiRO and Differentia Biotech collaborate on trial simulation
HiRO and Differentia Biotech collaborate on advanced clinical trial simulation models. Learn how this AI-driven partnership aims to support biopharmaceutical sp
By emily johnson · Aug 31, 2026
Microbiome Diversity
HaemaLogiX doses KMCAR T‑cell in KOALA trial
Discover the KMCAR T-cell dose in the KOALA Phase I trial, a promising CAR‑T option for relapsed or refractory kappa‑restricted multiple myeloma patients.
By Samoyed · Aug 30, 2026
Endocrine Balance
Amgen Drug Shows Promise in Inflammatory Diseases
Amgen's new drug shows promise in treating inflammatory diseases, potentially securing a new label addition for severe conditions like asthma and eosinophilic o
By Samoyed · Aug 29, 2026